Titan Spine names 1st CFO amid nanoLOCK growth: 5 things to know

Laura Dyrda -   Print  |

Titan Spine appointed Chad Kolean CFO.


Here are five things to know:


1. In his new role, Mr. Kolean will oversee Titan's financial team and build forward-looking financial preparedness as the company experiences growth following the launch of the nanoLOCK surface technology in October 2016.


"The growing demand for our technology and our strong sales team has led to significant growth, especially in the first half of this year, and we believe Chad will help drive our continued progress, further benefiting patients at the nano-cellular level to heal faster following spinal fusions," said Peter Ullrich, CEO of Titan Spine.


2. Mr. Kolean has experience as CFO of Cellectar Biosciences where he was responsible for management restructuring and raised funds that resulted in uplisting to the Nasdaq Capital Market. He also spent time as CFO of Pioneer Surgical Technologies.


3. Mr. Kolean earned his B.A. in business administration from Hope College in Holland, Mich.


4. Titan Spine named Mr. Kolean the company's first CFO.


5. In his early career, Mr. Kolean served as corporate controller for Tomotherapy and held multiple leadership positions at Metavante Corp., a provider of banking and payment technologies and services.


More articles on orthopedic devices:
Implanet receives FDA clearance for JAZZ passer: 4 takeaways
57 orthopedic devices receive FDA 510(k) clearance
Medtronic receives recognition for social responsibility

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers